Hold Torrent Pharma, may test Rs 1,800: Nooresh Merani

Nooresh Merani of Analyse India told CNBC-TV18, "Torrent Pharma has been in a strong uptrend for the past few years rather. In the near term also the stock has given a good support zones also. It has bounced back. So, what I look at is we are looking towards shorter-term target price of Rs 1,800 and in the long-term it could do much more. So, I would suggest a hold." "Sobha has given us sort of signs of bottoming out, so as of now one can continue to hold on and review after three months," he added.